Cue Biopharma, Inc. - COM (CUE)

Historical Portfolio Holders from Q1 2018 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
13.9M
Holdings value Q3 2024
$10.5M
Value change Q3 2024
-$289K
Grand Portfolio weight change Q3 2024
0%
Number of holders
49
Number of buys Q3 2024
11
Number of sells Q3 2024
-40
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 13.9M $10.5M -$289K $0.76 50
2024 Q2 13.8M $17.1M -$3.74M $1.24 71
2024 Q1 16.4M $31M +$2.72M $1.89 74
2023 Q4 14.9M $39.3M +$2.54M $2.64 80
2023 Q3 14M $32.1M -$635K $2.30 75
2023 Q2 13.8M $50.5M +$6.69M $3.65 77
2023 Q1 12.1M $43M -$2.54M $3.57 62
2022 Q4 12.8M $36.4M +$156K $2.85 61
2022 Q3 12.8M $28.7M -$3M $2.23 62
2022 Q2 14.1M $35M -$11M $2.49 68
2022 Q1 17.8M $87M +$4.49M $4.88 97
2021 Q4 16.5M $187M -$11.1M $11.31 88
2021 Q3 16.9M $246M -$24M $14.57 88
2021 Q2 18.6M $216M -$2.77M $11.65 89
2021 Q1 18.8M $230M -$6.45M $12.20 89
2020 Q4 19.3M $242M -$3.02M $12.51 94
2020 Q3 19.5M $294M +$50M $15.05 90
2020 Q2 16M $393M +$85M $24.51 99
2020 Q1 13M $185M +$36.6M $14.19 73
2019 Q4 10.6M $168M +$63.1M $15.88 60
2019 Q3 6.08M $51.3M +$13.3M $8.43 44
2019 Q2 4.5M $40.5M +$10M $8.99 36
2019 Q1 3.45M $26.7M +$1.83M $7.73 37
2018 Q4 3.23M $15.2M -$2.04M $4.70 34
2018 Q3 3.58M $32.4M +$3.24M $9.05 36
2018 Q2 3.15M $37.3M +$15.4M $11.86 37
2018 Q1 1.84M $25.9M +$25.9M $14.05 28